Nasopharyngeal News and Research

RSS

Clinical trial report endorses nitazoxanide as a safe drug for moderately ill COVID-19 patients

Researchers tested the safety and efficacy of 600 mg oral dose of nitazoxanide in mild or moderately ill COVID-19 patients.

3 Mar 2022

mRNA vaccines found to generate neutralizing antibodies against SARS-CoV-2 Omicron variant

A new study assessed the immunogenicity of messenger-ribonucleic acid vaccines to generate cross-reactive neutralizing antibodies against the SARS-CoV-2 Omicron variant in convalescent COVID-19 patients.

1 Mar 2022

Exploring Oxford nanopore technology-based on-site SARS-CoV-2 genome sequencing

In a new study, researchers performed genomic sequencing of SARS-CoV-2-infected samples and aimed to identify the dominant variant, assess the mutation profile, and determine the sample-to-sequence turnover time.

1 Mar 2022

Breakthrough SARS-CoV-2 infection peaks at 5 months

A new study describes the incidence of breakthrough infection with SARS-CoV-2 after vaccination with one of the nucleic acid or viral vector vaccines.

28 Feb 2022

Traditional Chinese medicine can be an effective radiosensitizer for patients with nasopharyngeal carcinoma

Treatment of nasopharyngeal carcinoma (NPC), a group of cancers that originate in the nose and throat, is made complicated by their unique position. Radiation therapy is often the main curative treatment for NPC. However, some patients are resistant to radiation therapy.

25 Feb 2022

Study shows SARS-CoV-2 hijacks mitochondrial transcriptional machinery resulting in organ failure and death

In a new study, researchers studied SARS-CoV-2 infection on the transcription of mitochondrial oxidative phosphorylation, glycolysis, nutrient sensing, and stress response genes.

24 Feb 2022

Study explores the effectiveness of Moderna COVID-19 vaccine against omicron, delta variants

New Kaiser Permanente research published February 21, 2022 in Nature Medicine shows that while Moderna COVID-19 vaccine protection is strong against coronavirus infection by the delta variant, it is not as strong against infection from the omicron variant.

23 Feb 2022

High nasopharyngeal viral load in SARS-CoV-2 Omicron-induced infection

In a recent study posted to the Research Square* pre-print server, a team of researchers from Italy and the United States (US) retrospectively reviewed and compared viral load in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron and previous SARS-CoV-2 strain-induced infection.

23 Feb 2022

Study explores the decline in viral load and immune response in COVID-19 patients

Researchers described the changes in viral ribonucleic acid the decline in viral load, and the immune response of SARS-CoV-2-infected patients, in a new preprint study.

22 Feb 2022

Study suggests anti-SARS-CoV-2 antibodies may persist lifelong post-infection

Researchers attempted to delineate the duration and stability of anti-SARS-CoV-2 antibodies in patients who had recovered from the COVID-19 infection.

22 Feb 2022

Research shows the impact of accessory genes deletion in SARS-CoV-2 evolution

In a recent study published in the journal PLoS ONE, researchers investigated the effect of genetic variability based on accessory gene deletions on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission and the clinical severity of coronavirus disease 2019 (COVID-19).

22 Feb 2022

Study reports potently neutralizing mucosal IgA in saliva of BNT162b2 vaccine recipients

researchers determine the strong neutralizing mucosal component emanating from intramuscular administration of an mRNA vaccine.

21 Feb 2022

SARS-CoV-2 Mpro inhibitor, nirmatrelvir, found to reduce COVID-19 progression and death

In a new study, researchers evaluated the efficacy and safety of nirmatrelvir in mild to moderate COVID-19 patients who were at high risk of severe COVID-19 disease.

18 Feb 2022

How accurate are rapid antigen COVID tests?

A new study updates the state of knowledge about antigen rapid diagnostic tests (Ag-RDT) in the diagnosis of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

17 Feb 2022

First cases of co-infection with Delta and Omicron identified during local co-circulation of both SARS-CoV-2 lineages

Researchers revealed the co-infection of the SARS-CoV-2 Delta and Omicron variants in two epidemiologically unrelated patients suffering from chronic kidney disease and requiring hemodialysis

17 Feb 2022

Pregnancy outcomes of pregnant women infected by SARS-CoV-2

A new study evaluated the pregnancy outcomes of pregnant women in the third trimester who were infected by SARS-CoV-2 for the detection of the virus in the placenta and different samples of the newborn as well as detection of antibodies in the cord blood.

16 Feb 2022

Nasopharyngeal News and Research

Clinical trial report endorses nitazoxanide as a safe drug for moderately ill COVID-19 patients

mRNA vaccines found to generate neutralizing antibodies against SARS-CoV-2 Omicron variant

Exploring Oxford nanopore technology-based on-site SARS-CoV-2 genome sequencing

Breakthrough SARS-CoV-2 infection peaks at 5 months

Traditional Chinese medicine can be an effective radiosensitizer for patients with nasopharyngeal carcinoma

Study shows SARS-CoV-2 hijacks mitochondrial transcriptional machinery resulting in organ failure and death

Study explores the effectiveness of Moderna COVID-19 vaccine against omicron, delta variants

High nasopharyngeal viral load in SARS-CoV-2 Omicron-induced infection

Study explores the decline in viral load and immune response in COVID-19 patients

Study suggests anti-SARS-CoV-2 antibodies may persist lifelong post-infection

Research shows the impact of accessory genes deletion in SARS-CoV-2 evolution

Study reports potently neutralizing mucosal IgA in saliva of BNT162b2 vaccine recipients

SARS-CoV-2 Mpro inhibitor, nirmatrelvir, found to reduce COVID-19 progression and death

How accurate are rapid antigen COVID tests?

First cases of co-infection with Delta and Omicron identified during local co-circulation of both SARS-CoV-2 lineages

Pregnancy outcomes of pregnant women infected by SARS-CoV-2

Study explores SARS-CoV-2 antibodies in children

First survey on Omicron BA.2 in France

New COVID-19 test can determine if individuals have been vaccinated, infected, both, or neither

New reagent-free SARS-CoV-2 detection technique based on machine learning and Raman spectroscopy

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News